Plexera Inks Exclusive Content Deal for DNA-based Protein Chips

Plexera Bioscience LLC, a wholly owned subsidiary of Lumera Corporation (NASDAQ:LMRA), announced today an option agreement with Auguron Biosciences, Inc, giving them rights to exclusive access to use Auguron’s Nucleic Acid Programmable Protein Array (NAPPA) technology on the Plexera Kx(TM) Array Platform.

Source: Lumera